Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study - Bouhassira, Didier; Wilhelm, Stefan; Schacht, Alexander; Perrot, Serge; Kosek, Eva; Cruccu, Giorgio; Freynhagen, Rainer; Tesfaye, Solomon; Lledó, Alberto; Choy, Ernest; Marchettini, Paolo; Micó, Juan Antonio; et al. (Pain (Amsterdam), 2014)
Keywords: Aged; Aged, 80 and over; Analgesics - therapeutic use; Biological and medical sciences; Diabetes. Impaired glucose tolerance; Diabetic Neuropathies - complications; Diabetic Neuropathies - drug therapy; Diabetic neuropathy; Double-Blind Method; Duloxetine; Duloxetine Hydrochloride - therapeutic use; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Female; Humans; Male; Medical sciences; Middle Aged; Nervous system involvement in other diseases. Miscellaneous; Neuralgia - complications; Neuralgia - diagnosis; Neurology; Neuropathic Pain Symptom Inventory; Pregabalin; Pregabalin - therapeutic use; Sensory symptoms; Severity of Illness Index; Stratified treatment; Treatment Outcome; Stratified treatment; Diabetic neuropathy; Sensory symptoms; Neuropathic Pain Symptom Inventory; Duloxetine; Pregabalin; Endocrinopathy; Nervous system diseases; Questionnaire; Diabetes mellitus; Psychometrics; Neuropathy; Neuropathic pain; Symptomatology; Treatment; Double blind study; Predictive factor